Prognostic impact of secondary prevention medical therapy in patients with Takotsubo cardiomyopathy: a Bayesian network meta-analysis

Back

ESC2024 Premium Access

Prognostic impact of secondary prevention medical therapy in patients with Takotsubo cardiomyopathy: a Bayesian network meta-analysis

Session: Takotsubo cardiomyopathy and acute coronary syndromes

Topic: Pharmacotherapy

Speaker: Doctor A. Zaka (Southport, AU)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Ammar Zaka

Gold Coast University Hospital, Southport (Australia)

0 follower

5 more presentations in this session

Cardiac autonomic dysfunction in Takotsubo cardiomyopathy: an observational study

Speaker: Doctor F. Hofer (Innsbruck, AT)

Clinical characteristics and outcomes of patients with takotsubo syndrome and dynamic left ventricular outflow tract obstruction

Speaker: Doctor D. Di Vece (Greifswald, DE)

A personalized, 3D printed, polymeric elastic support device for the prevention of post-MI cardiac remodeling

Speaker: Doctor D. Nachman (Jerusalem, IL)

Guideline-directed medical therapy titration for heart failure with ischaemic aetiology and its effect on cardiac remodelling and cardiovascular mortality-from a real world perspective

Speaker: Doctor J. Bonini (Ferrara, IT)

Utility of venoarterial extracorporeal membrane oxygenation in patients with acute myocardial infarction complicated by cardiogenic shock

Speaker: Doctor S. Gupta (Stony Brook, US)

Access the full session

Takotsubo cardiomyopathy and acute coronary syndromes

Speakers: Doctor A. Zaka, Doctor F. Hofer, Doctor D. Di Vece, Doctor D. Nachman, Doctor J. Bonini...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources